Home

Casp9 (rat)

Overview Casp9 a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. This protein is processed by caspase APAF1; this step is thought to be one of the earliest in the caspase activation cascade. Alternative splicing results in two isoforms. Note: This description may include information from UniProtKB. Protein type: EC 3.4.22.62; Apoptosis; Protease Cellular Component: mitochondrion; cytoplasm; nucleus; cytosol; apoptosome Molecular Function: peptidase activity; protein binding; peptide binding; cysteine-type peptidase activity Biological Process: caspase activation; metabolic process; apoptosis; positive regulation of apoptosis; response to lipopolysaccharide; proteolysis; response to organic cyclic substance; response to estradiol stimulus; response to antibiotic; positive regulation of neuron apoptosis; induction of apoptosis; response to cobalt ion; response to DNA damage stimulus; response to UV; aging Reference #:  Q9JHK1 (UniProtKB) Alt. Names/Synonyms: 25 kDa caspase-9 dominant negative protein; Apaf3; apoptotic protease activating factor 3; apoptotic protease Mch-6; Casp-9-CTD; Casp9; Casp9_v1; caspase 9, apoptosis-related cysteine peptidase; Caspase 9, isoform CRA_a; Caspase-9; caspase-9 dominant negative form; Caspase-9 long isoform; caspase-9-carboxyl-terminal divergent; Ice-Lap6; Ice-like apoptotic protease 6; Mch6; RNCASP9 Gene Symbols: Casp9 Molecular weight: 50,400 Da Basal Isoelectric point: 6.04  Predict pI for various phosphorylation states CST Pathways:  Alzheimer's Disease  |  Apoptosis  |  Death Receptor Signaling  |  ErbB/HER Signaling  |  Inhibition of Apoptosis  |  Mitochondrial Control of Apoptosis Protein-Specific Antibodies or siRNAs from Cell Signaling Technology®

Select Structure to View Below Casp9 1JXQ - A/B/C/D=140-416 (human) 1NW9 - B=140-416 (human) 2AR9 - A/B/C/D=140-416 (human) 3D9T - D/C=316-321 (human) 3V3K - A/O/M/C/K/I/G/E=141-416 (human) 3YGS - P=1-95 (human)

STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  ENZYME  |  UCSD-Nature  |  UniProtKB  |  Entrez-Gene  |  Ensembl Gene

	Modification Sites and Domains

	Modification Sites in Parent Protein, Orthologs, and Isoforms

SS  SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.	MS  MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.			rat
1	0		S132	KVVKLDPSQPALGNL
6	5		T163	PEVLTPETPRPVDIG
1	0		K182	HDVCTPGKIERHADM
1	0		Y191	ERHADMAYTLDSDPC
0	1		S213	NVNFCPSSGLSTRIG
1	0		S221	GLSTRIGSHVDCEKL
1	0		C233	EKLQHRFCWLRFMVE
2	1		W234	KLQHRFCWLRFMVEV
0	1		S340	GFEVAFTSSQDKAFD
0	2		A345	FTSSQDKAFDsDSEP
1	1		S348-p	SQDKAFDsDSEPDAV

	human
S99-p	NRQAAKLsKPTLENL
T125-p	PEVLRPEtPRPVDIG
S144-p	GDVGALEsLRGNADL
Y153-p	RGNADLAyILSMEPC
S175-p	NVNFCREsGLRTRTG
S183-p	GLRTRTGsNIDCEKL
S195-p	EKLRRRFssLHFMVE
S196-p	KLRRRFssLHFMVEV
S302-p	GFEVASTsPEDEsPG
S307-p	STsPEDEsPGsNPEP
S310-p	PEDEsPGsNPEPDAT

	mouse
S132	RVVKLEPSQPAVGNL
T163-p	PEVLRPEtPRPVDIG
K182	HDVCVPGKIRGHADM
Y191	RGHADMAYTLDSDPC
S213	NVNFCPSSGLGTRTG
S221	GLGTRTGSNLDRDKL
R233	DKLEHRFRWLRFMVE
W234	KLEHRFRWLRFMVEV
S340	GFEVACTSSQGRTLD
T345	CTSSQGRTLDsDSEP
S348-p	SQGRTLDsDSEPDAV

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E Produced by 3rd Millennium  |  Design by Digizyme ©2003-2013 Cell Signaling Technology, Inc.